Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MGP mRNA | affects expression | 20406850
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of MGP mRNA | decreases expression | 18289764
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of MGP mRNA | decreases expression | 16514628
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of MGP mRNA | decreases expression | 15282401
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MGP mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of MGP mRNA | increases expression | 20458559
|
D001414 |
Bacitracin |
Bacitracin results in increased expression of MGP mRNA | increases expression | 18289764
|
C447119 |
bazedoxifene acetate |
bazedoxifene acetate results in decreased expression of MGP mRNA | decreases expression | 19914376
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MGP mRNA | affects cotreatment|increases expression | 18164116
|
C031463 |
beta-glycerophosphoric acid |
beta-glycerophosphoric acid results in decreased expression of MGP mRNA | decreases expression | 17171500
|
C031463 |
beta-glycerophosphoric acid |
Calcitriol promotes the reaction [beta-glycerophosphoric acid results in decreased expression of MGP mRNA] | decreases expression|increases reaction | 17171500
|
C031463 |
beta-glycerophosphoric acid |
paricalcitol promotes the reaction [beta-glycerophosphoric acid results in decreased expression of MGP mRNA] | decreases expression|increases reaction | 17171500
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MGP mRNA | decreases expression | 15336504 12766906
|
D002104 |
Cadmium |
Cadmium results in increased expression of MGP mRNA | increases expression | 17327699
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of MGP mRNA | increases expression | 17327699
|
D002118 |
Calcium |
Calcium binds to MGP protein | affects binding | 18369157
|
D002118 |
Calcium |
[Calcium binds to MGP protein] which binds to and results in decreased activity of BMP4 protein | affects binding|decreases activity | 18369157
|
D002118 |
Calcium |
Edetic Acid inhibits the reaction [Calcium binds to MGP protein] | affects binding|decreases reaction | 18369157
|
D002118 |
Calcium |
[Edetic Acid inhibits the reaction [Calcium binds to MGP protein]] inhibits the reaction [MGP protein binds to BMP4 protein] | affects binding|decreases reaction | 18369157
|
D002118 |
Calcium |
Calcium affects the expression of MGP mRNA | affects expression | 15913539
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MGP mRNA | affects expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of MGP mRNA | increases expression | 16239168
|
D002794 |
Choline |
Choline affects the expression of MGP mRNA | affects expression | 17616785
|
C030123 |
coumarin |
coumarin results in decreased expression of MGP mRNA | decreases expression | 19350115
|
C030123 |
coumarin |
coumarin results in decreased expression of MGP mRNA | decreases expression | 19350115
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MGP mRNA | decreases expression | 20106945
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of MGP mRNA | increases expression | 15829613
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of MGP mRNA | increases expression | 18289764
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MGP mRNA | affects cotreatment|increases expression | 18164116
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of MGP mRNA | increases expression | 19638242
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [beta-glycerophosphoric acid results in decreased expression of MGP mRNA] | decreases expression|increases reaction | 17171500
|
D004492 |
Edetic Acid |
Edetic Acid inhibits the reaction [Calcium binds to MGP protein] | affects binding|decreases reaction | 18369157
|
D004492 |
Edetic Acid |
[Edetic Acid inhibits the reaction [Calcium binds to MGP protein]] inhibits the reaction [MGP protein binds to BMP4 protein] | affects binding|decreases reaction | 18369157
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MGP mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of MGP mRNA | increases expression | 16202921 16514628 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MGP mRNA | decreases expression | 19400957
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MGP mRNA | decreases expression | 12655037 17557909 19400957
|
D012968 |
Etidronic Acid |
Etidronic Acid results in increased expression of MGP mRNA | increases expression | 17270170
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of MGP mRNA | decreases expression | 16514628
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of MGP mRNA | increases expression | 18289764
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of MGP mRNA | affects cotreatment|increases expression | 17183730
|
D007654 |
Ketoconazole |
Ketoconazole affects the expression of MGP mRNA | affects expression | 18289764
|
D015058 |
1-Naphthylisothiocyanate |
1-Naphthylisothiocyanate results in increased expression of MGP mRNA | increases expression | 18289764
|
C084656 |
paricalcitol |
paricalcitol promotes the reaction [beta-glycerophosphoric acid results in decreased expression of MGP mRNA] | decreases expression|increases reaction | 17171500
|
C084656 |
paricalcitol |
[Phosphorus co-treated with paricalcitol] results in increased expression of MGP mRNA | affects cotreatment|increases expression | 17715259
|
C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in increased expression of MGP mRNA | increases expression | 17560707
|
D010758 |
Phosphorus |
[Phosphorus co-treated with paricalcitol] results in increased expression of MGP mRNA | affects cotreatment|increases expression | 17715259
|
C035988 |
procymidone |
procymidone results in increased expression of MGP mRNA | increases expression | 15686871
|
D011374 |
Progesterone |
Progesterone results in decreased expression of MGP mRNA | decreases expression | 18070364
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of MGP mRNA | decreases expression | 16514628
|
D012643 |
Selenium |
Selenium results in increased expression of MGP mRNA | increases expression | 18583539
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of MGP mRNA | decreases expression | 19400957
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of MGP mRNA | decreases expression | 19400957
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MGP mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MGP mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MGP mRNA | decreases expression | 11752688
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of MGP mRNA | increases expression | 17982090
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of MGP mRNA | affects cotreatment|increases expression | 17183730
|
D014640 |
Vancomycin |
Vancomycin results in increased expression of MGP mRNA | increases expression | 18289764
|
C025643 |
vinclozolin |
vinclozolin affects the expression of MGP mRNA | affects expression | 19015723
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of MGP mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.06 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.74 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
6.74 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.50 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.08 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.46 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.73 | 17670903 15814532 12690470 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
7.73 | 11274264 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
8.99 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
8.99 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
8.99 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
8.99 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
9.54 | 3712494 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
9.54 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
9.54 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
8.47 | 17162532 19052882 16434500 19061943 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.47 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.14 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.43 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.75 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.54 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
7.60 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
7.60 | 19015723 |
OMIM:109730 |
AORTIC VALVE DISEASE |
marker/mechanism |
|
| 19350115 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.00 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.36 | 15885639 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.35 | 15687053 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.40 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Choline |
2.57 | 16818868 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.57 | 18940202 17507914 18177632 18316065 17157402 20603192 18396377 15238991 19232924 19460635 18558336 18985861 18775368 16609825 17688650 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.53 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.82 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
7.55 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.55 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.97 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.97 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.40 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.85 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
9.42 | 15665606 15845082 15380490 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
9.42 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
5.24 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
5.24 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
5.24 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.24 | 12948864 14630087 17289903 17261762 19861407 16675129 18497071 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
5.24 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
5.24 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
5.24 | 15775269 17440819 17242785 15758505 17049068 15572757 16837676 17893378 17595753 17952589 16912660 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
5.24 | 20390343 19115204 19244106 19189212 18821012 19142967 19487384 11161223 20005174 19189210 18425577 18629630 20859285 17242785 19410462 20135344 19288272 19084267 21138602 17893378 19066611 18815881 16873071 20544844 18997820 15565566 17261762 19221464 17049068 19059307 15668708 19155303 21152245 16202921 16818667 18351453 19289846 18855134 20065188 19011961 17440819 16273361 18984771 19103187 19200415 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.24 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.89 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.99 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
8.39 | 3786805 15700767 18705752 15721981 16192424 16227642 16011737 15673190 10355542 16124888 16097048 16050911 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
8.39 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.42 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.04 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
15.21 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
15.21 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.21 | 14691202 15073043 16217749 11135700 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
15.21 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
15.21 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
15.21 | 17761372 17428255 16502159 19701751 18788625 21159647 16681979 16807293 18971187 18978308 17173139 20101231 19919837 18785209 19171122 19335982 16328049 17162532 17978847 20084675 16935385 3581430 19208518 19394651 20432363 19519916 16878318 16779866 16288022 20512989 18665156 16698587 18210153 20524982 10672840 20007298 19052882 16830150 18056438 19822196 16569478 18494052 17138121 16540662 20727157 11831363 10737359 20935162 20214788 19107877 18691550 19383236 18506893 20514400 18393292 19539802 19418558 3084413 17055752 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.21 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
15.21 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.86 | 12023789 16685392 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.39 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.44 | 7296757 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.70 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.44 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
4.44 | 17066447 6189445 18337622 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.13 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.13 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.09 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.11 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
22.02 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
22.02 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
22.02 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
22.02 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
22.02 | 17174075 21159647 7505956 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
22.02 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.52 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.99 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.99 | 16835633 |
MESH:D002761 |
Cholangitis |
|
1-Naphthylisothiocyanate |
5.71 | 12912871 |
MESH:D002779 |
Cholestasis |
|
1-Naphthylisothiocyanate |
16.36 | 12927374 15500046 7624871 15913567 16629650 19486331 18590720 18164287 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
16.36 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.36 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.36 | 15861022 11677210 16919318 17333356 16105132 17681005 17110522 |
MESH:D002780 |
Cholestasis, Intrahepatic |
|
1-Naphthylisothiocyanate |
5.37 | 19407337 10220858 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.89 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.15 | 15800139 |
MESH:D003092 |
Colitis |
|
Selenium |
8.27 | 17936198 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
8.27 | 18200517 17991707 16782535 16867261 11698051 17936198 16474422 18023891 16804969 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.27 | 17276891 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.53 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.53 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.66 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.73 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.86 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.86 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.86 | 17688650 8888407 16575769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
4.86 | 19769572 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
10.19 | 16037377 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
10.19 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.55 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.66 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.90 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.76 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.37 | 12868966 11906362 18759878 14531868 8156756 2524372 8970840 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.05 | 2952479 3621924 |
MESH:D002658 |
Developmental Disabilities |
|
Choline |
4.35 | 16818868 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
coumarin |
6.37 | 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.37 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.37 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
12.70 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
12.70 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
12.70 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.03 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-Naphthylisothiocyanate |
22.62 | 17522070 7624871 18289764 20133375 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
22.62 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
22.62 | 6482804 6679447 18648102 18289764 11289319 18692083 8291058 16192314 1440618 7440962 9022650 9653073 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
22.62 | 3786805 19085960 15968718 7440962 7120509 2869522 15998439 16177239 15027814 10092053 11566570 6884620 7179309 21278145 6623471 16227642 3732212 10915739 19336974 17522070 9327722 4309450 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
22.62 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ketoconazole |
22.62 | 18289764 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
22.62 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
22.62 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
22.62 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
11.81 | 12649298 12231392 19839026 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
11.81 | 15033597 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
11.81 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.61 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.22 | 9068938 |
MESH:D004487 |
Edema |
|
Raloxifene |
5.47 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.47 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.42 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
23.94 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
23.94 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
23.94 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
23.94 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
23.94 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
10.70 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.70 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
10.70 | 19155303 20544844 17893378 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.56 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.56 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.69 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.43 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.68 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.19 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.83 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.59 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.63 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.46 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.46 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
6.46 | 15464296 17638652 15173087 16481741 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.65 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
35.87 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
35.87 | 61145 19224547 12795759 15959796 12631006 16045604 17595544 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
35.87 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
35.87 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
35.87 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
35.87 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
35.87 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
35.87 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.94 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.99 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.40 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.68 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.53 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.05 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.71 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
17.36 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
17.36 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
17.36 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
17.36 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.81 | 16904648 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.46 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.81 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.74 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
3.95 | 17162496 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.60 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.11 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.39 | 15102660 15464296 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
8.95 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
8.95 | 18024279 19130971 15968427 17868369 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.03 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.68 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
5.68 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.20 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Selenium |
2.77 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.94 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.91 | 11000095 |
MESH:D006505 |
Hepatitis |
|
1-Naphthylisothiocyanate |
13.18 | 18590720 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
13.18 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
13.18 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.52 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.55 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.21 | 16170182 16200630 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
8.44 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
8.44 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.39 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.05 | 16899240 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.23 | 17652376 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.47 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.40 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
7.40 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.40 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.62 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.16 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.34 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.94 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.02 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.42 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
9.42 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
9.42 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
9.77 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
9.77 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
9.77 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.77 | 12878042 12200463 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.37 | 18200517 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
9.34 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
9.34 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.65 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
4.14 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.53 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.95 | 15604871 |
MESH:C536167 |
Keutel syndrome |
marker/mechanism |
|
| |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
11.70 | 15464296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
11.70 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Bacitracin |
33.53 | 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
33.53 | 16226777 16962696 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
33.53 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
33.53 | 19839026 18289764 12231392 12649298 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
33.53 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
33.53 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
33.53 | 17934191 18289764 19349640 |
MESH:D007674 |
Kidney Diseases |
|
Vancomycin |
33.53 | 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
33.53 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.46 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
19.22 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
19.22 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
19.22 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
19.22 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
19.22 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
17.02 | 16316344 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
17.02 | 11231351 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
17.02 | 11231351 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.06 | 16973256 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
7.88 | 10219319 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Ketoconazole |
7.88 | 1311351 8889330 19744259 2166429 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Ketoconazole |
4.18 | 11332679 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.58 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.37 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.83 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.07 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.34 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.56 | 16467208 17050201 19850784 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.56 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
2.90 | 19225113 17107899 17217047 12712474 17869043 12018890 11161223 11468182 15748426 16891316 19075265 16112521 15336539 19642359 16331271 9834237 15622746 17712046 12679006 19035177 16330433 16823087 16966277 17649720 15213294 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.90 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.25 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Ketoconazole |
7.15 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.15 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.69 | 16221502 16943688 16239168 11408273 17157831 17174718 17334410 11903743 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.69 | 18407596 19638242 18665156 20032147 18522880 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.89 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
5.94 | 18006644 18339082 12649538 18420326 16136751 18187930 14512876 15931870 15925388 12609069 18412020 15123356 14716496 14716833 17869086 18481824 14620537 15052691 15818738 17900296 18277467 18166357 12632514 16097048 18472332 16027843 12667390 17766677 15370692 18205269 12898905 16011737 17481882 17565644 17557913 18317297 18472094 17944888 15673190 18395095 16248980 16116963 18395914 15057751 12389079 18705752 18054572 18279442 14748882 15996030 17922224 18263696 15338365 12632512 17525996 16192424 18418968 16033810 12445418 10355542 18376398 17631135 15876570 14724832 17761835 17721639 17805973 12741479 16015684 15959796 17714472 18429990 18156304 12586293 17640975 15650968 15730626 15893842 17823541 16638106 12445421 11481614 17708605 17976157 12666154 20821823 12546737 15362042 13678700 12958196 18251166 18210741 17698563 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.94 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
5.94 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.94 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
5.94 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
1-Naphthylisothiocyanate |
5.83 | 17184895 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.83 | 16964402 16246199 15720792 17285989 15830285 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
5.83 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.70 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.28 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
18.78 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
18.78 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
18.78 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
18.78 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.78 | 21278145 20452335 9163691 20101389 19833225 2422723 19850985 20137499 19499222 18754104 19642983 19254457 21047994 12771043 21071580 19690152 19638242 19812893 20405173 12112319 21167192 15175105 19427195 19090486 20492335 18978307 10737359 18648771 16942905 19551842 2862719 20501860 20434301 19294768 19426721 18977376 15885732 18644402 20583210 20118626 19996281 19255062 19256749 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
18.78 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
23.54 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
23.54 | 3712494 6587162 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
23.54 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
23.54 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
23.54 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
23.54 | 21159647 19004024 18308698 16267830 19126423 2563599 3124819 18544905 16842330 18775883 18253720 19539802 17942915 19009564 17854601 17174075 18282651 18079962 18093689 19519916 9362446 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
23.54 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.99 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
2.85 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.78 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
7.59 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
7.59 | 11798837 17225452 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
7.59 | 20970405 6695378 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
7.59 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.59 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
7.59 | 11062179 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.29 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.68 | 16891317 17203775 11807958 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
11.68 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
11.68 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
11.68 | 14580682 16827153 11731420 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.03 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.03 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
3.16 | 18176117 18505091 12883367 17761969 11135225 16809738 12393984 15577323 18332650 17023156 12374674 16248763 16432458 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.16 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
9.92 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
9.92 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
5.66 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
5.66 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.30 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.85 | 18765137 18803445 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.07 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
6.27 | 15949261 19417148 14977855 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
6.27 | 16497877 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
5.79 | 18694830 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.60 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.19 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.47 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.47 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.64 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.91 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.07 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.39 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.51 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.23 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.23 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.23 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.35 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
2.71 | 16773208 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.52 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.26 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.01 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.95 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.88 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
7.96 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
7.96 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
10.28 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.28 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
10.28 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.19 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
2.96 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.22 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.63 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.51 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
7.51 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.53 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
10.63 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Etidronic Acid |
10.63 | 17042918 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
10.63 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.79 | 15579764 17823083 15758505 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
9.89 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
9.89 | 17225452 15464296 6897625 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
9.89 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
9.89 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
7.56 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
7.56 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.56 | 16540662 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
3.77 | 17698068 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.25 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.02 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.72 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
1-Naphthylisothiocyanate |
12.17 | 20133375 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
12.17 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.86 | 15464296 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
4.91 | 15687053 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.98 | 6228378 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.40 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.86 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.11 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.61 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.61 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.48 | 11896295 11118676 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
13.48 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
13.48 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.46 | 18220299 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.30 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.46 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.31 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.31 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.31 | 12479363 16289102 18247401 16644109 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.31 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ketoconazole |
2.31 | 17404083 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.31 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.31 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.31 | 15084515 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.46 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.29 | 15033597 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.84 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.06 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.05 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.07 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.12 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
9.12 | 15728788 17132701 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.02 | 3692021 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
5.79 | 18644591 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.73 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.67 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.84 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
8.84 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.00 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
4.86 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
4.86 | 1511512 11738929 15475178 16876388 3137016 17978042 14763951 11044598 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.31 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
4.79 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
4.79 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.86 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.94 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
9.94 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.29 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.29 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.41 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.06 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.13 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
3.13 | 15958060 17522103 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.13 | 18456281 |
MESH:D020521 |
Stroke |
|
Raloxifene |
7.45 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
7.45 | 16517955 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.19 | 17225452 15464296 |
MESH:D013921 |
Thrombocytopenia |
|
1-Naphthylisothiocyanate |
4.34 | 20133375 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.18 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.75 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.42 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.85 | 7505956 1399818 6587162 6582329 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
9.85 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
9.85 | 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.09 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.09 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.49 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.75 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.04 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
17.17 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.17 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
17.17 | 12973940 20435036 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
17.17 | 15464296 17225452 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
17.17 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
17.17 | 16712894 17572228 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.18 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.84 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
3.80 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.85 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.50 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.15 | 15577323 |
MESH:D014648 |
Varicose Veins |
marker/mechanism |
|
| 17643059 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.11 | 12125929 |
MESH:D014689 |
Venous Insufficiency |
|
coumarin |
5.29 | 12708602 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.72 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.11 | 14671159 15869587 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.07 | 18776599 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.23 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.07 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.76 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.95 | 17120751 |